Header Logo

Jeffrey Borgia

Concepts (322)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
29
2024
551
7.910
Why?
Carcinoma, Non-Small-Cell Lung
21
2024
242
7.020
Why?
Biomarkers, Tumor
12
2024
205
4.120
Why?
Autoantibodies
5
2021
80
1.900
Why?
Multiple Pulmonary Nodules
3
2022
11
1.800
Why?
Insulin-Like Growth Factor I
6
2024
59
1.400
Why?
Biomarkers
9
2024
561
1.270
Why?
Neoplasm Recurrence, Local
4
2017
205
1.120
Why?
Immunoassay
3
2018
37
1.090
Why?
Insulin-Like Growth Factor Binding Proteins
3
2015
10
0.960
Why?
Body Composition
2
2024
68
0.930
Why?
Solitary Pulmonary Nodule
2
2015
14
0.890
Why?
Prognosis
10
2024
781
0.890
Why?
Adenocarcinoma
5
2018
137
0.880
Why?
Drug Resistance, Neoplasm
3
2020
69
0.880
Why?
Humans
48
2024
26946
0.870
Why?
Neoplasm Staging
7
2024
362
0.790
Why?
Middle Aged
21
2024
8887
0.790
Why?
Immunotherapy
2
2024
57
0.750
Why?
Early Detection of Cancer
5
2022
103
0.740
Why?
Aged
21
2024
8979
0.740
Why?
Cachexia
2
2019
12
0.710
Why?
Antineoplastic Agents, Immunological
1
2021
15
0.710
Why?
Lymphoma, Non-Hodgkin
2
2019
36
0.700
Why?
Aged, 80 and over
13
2024
4771
0.690
Why?
Female
25
2024
15166
0.660
Why?
Male
24
2024
14718
0.660
Why?
HLA Antigens
2
2021
14
0.640
Why?
Algorithms
7
2022
348
0.640
Why?
Erlotinib Hydrochloride
2
2020
11
0.640
Why?
Histocompatibility Antigens Class II
1
2018
6
0.600
Why?
Histocompatibility Antigens Class I
1
2018
14
0.590
Why?
Syndecan-1
1
2018
5
0.590
Why?
Vimentin
2
2016
2
0.580
Why?
Neovascularization, Pathologic
2
2015
36
0.580
Why?
Inflammation Mediators
1
2018
66
0.570
Why?
Nerve Growth Factors
1
2018
38
0.570
Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
36
0.540
Why?
Tandem Mass Spectrometry
2
2013
20
0.520
Why?
Lymphatic Metastasis
3
2012
92
0.520
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2017
244
0.510
Why?
Kidney Transplantation
2
2016
119
0.510
Why?
Cytokines
2
2014
221
0.470
Why?
Graft Rejection
2
2016
66
0.470
Why?
Insulin-Like Growth Factor II
1
2014
10
0.470
Why?
Predictive Value of Tests
5
2014
474
0.460
Why?
Adult
12
2018
7793
0.460
Why?
Doxazosin
1
2013
1
0.440
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2013
1
0.440
Why?
Chloroquine
1
2013
7
0.430
Why?
Melanins
1
2013
7
0.430
Why?
Cohort Studies
7
2024
1882
0.430
Why?
Immunoglobulin G
3
2022
80
0.430
Why?
Sulfonamides
1
2013
37
0.430
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
11
0.410
Why?
Multivariate Analysis
4
2017
326
0.400
Why?
Immunoglobulin M
2
2022
12
0.400
Why?
C-Peptide
1
2011
5
0.380
Why?
Sensitivity and Specificity
3
2022
479
0.380
Why?
Cell Line, Tumor
7
2020
255
0.370
Why?
Retrospective Studies
7
2019
3522
0.370
Why?
Blood Chemical Analysis
1
2010
17
0.350
Why?
Survival Analysis
3
2021
256
0.350
Why?
Hematologic Tests
1
2010
6
0.350
Why?
Protein Array Analysis
1
2010
10
0.350
Why?
Protein Kinase Inhibitors
3
2020
53
0.340
Why?
ErbB Receptors
4
2020
54
0.330
Why?
Area Under Curve
4
2014
63
0.320
Why?
Lymph Nodes
1
2009
72
0.300
Why?
Disease-Free Survival
3
2017
174
0.300
Why?
Treatment Outcome
6
2024
3454
0.290
Why?
Risk Assessment
4
2017
626
0.290
Why?
Body Weight
3
2024
134
0.280
Why?
Antigens, Neoplasm
2
2021
41
0.260
Why?
Diagnosis, Differential
2
2018
348
0.250
Why?
Gene Expression Profiling
2
2024
138
0.240
Why?
Antibodies, Viral
2
2022
55
0.240
Why?
Animals
11
2020
3627
0.240
Why?
Proteomics
2
2018
89
0.220
Why?
Young Adult
4
2018
1984
0.210
Why?
Chondrocytes
3
2014
140
0.210
Why?
ROC Curve
2
2014
141
0.210
Why?
Reproducibility of Results
3
2014
673
0.210
Why?
Pneumonectomy
2
2017
77
0.210
Why?
Prospective Studies
3
2024
1771
0.210
Why?
Survival Rate
2
2018
340
0.210
Why?
Diabetes Mellitus, Type 2
2
2016
167
0.210
Why?
Vaccines
1
2022
8
0.200
Why?
Mutation
3
2020
347
0.200
Why?
Immunoglobulin E
1
2022
11
0.200
Why?
Immunoglobulin A
1
2022
14
0.200
Why?
Gene Expression Regulation, Neoplastic
3
2024
116
0.200
Why?
Complement C1q
1
2022
9
0.200
Why?
Seroconversion
1
2022
1
0.200
Why?
Sarcopenia
2
2019
31
0.200
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.200
Why?
Spike Glycoprotein, Coronavirus
1
2022
17
0.190
Why?
Body Mass Index
1
2024
457
0.190
Why?
Organoids
1
2021
7
0.190
Why?
Precision Medicine
1
2021
26
0.180
Why?
Neoplasms
2
2021
237
0.180
Why?
Follow-Up Studies
2
2018
1784
0.180
Why?
Tomography, X-Ray Computed
2
2015
683
0.180
Why?
Neoplasm Invasiveness
3
2017
93
0.180
Why?
Bone Morphogenetic Protein 7
2
2011
30
0.180
Why?
B7-H1 Antigen
1
2021
8
0.180
Why?
Pilot Projects
1
2022
417
0.180
Why?
Proportional Hazards Models
3
2017
346
0.180
Why?
Programmed Cell Death 1 Receptor
1
2021
17
0.180
Why?
Observer Variation
1
2021
93
0.180
Why?
Endothelin-1
1
2020
3
0.180
Why?
Disease Progression
2
2014
673
0.170
Why?
Biochemistry
1
2000
1
0.170
Why?
Colorectal Neoplasms
1
2022
111
0.170
Why?
Mass Screening
1
2022
168
0.170
Why?
Cardiovascular Diseases
1
2024
321
0.170
Why?
Proteins
1
2000
65
0.170
Why?
Weight Loss
2
2019
127
0.160
Why?
Receptors, CXCR
1
2019
1
0.160
Why?
Patient Selection
1
2021
192
0.160
Why?
Esophagectomy
1
2019
23
0.160
Why?
Epithelial-Mesenchymal Transition
2
2019
6
0.160
Why?
Protein Binding
3
2014
126
0.160
Why?
Esophageal Neoplasms
1
2019
50
0.160
Why?
RNA, Small Untranslated
1
2018
1
0.150
Why?
Channelopathies
1
2018
5
0.150
Why?
CA1 Region, Hippocampal
1
2018
8
0.150
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2018
10
0.150
Why?
Cell Movement
2
2016
79
0.150
Why?
Carcinoma, Large Cell
1
2018
12
0.150
Why?
Transcriptome
3
2024
87
0.150
Why?
Pyramidal Cells
1
2018
34
0.150
Why?
Neuronal Plasticity
1
2018
46
0.150
Why?
SOS1 Protein
1
2016
4
0.130
Why?
Proto-Oncogene Proteins c-cbl
1
2016
12
0.130
Why?
rac1 GTP-Binding Protein
1
2016
14
0.130
Why?
Kidney Tubules
1
2016
6
0.130
Why?
Carcinoma, Squamous Cell
1
2018
171
0.130
Why?
Adaptor Proteins, Vesicular Transport
1
2016
42
0.130
Why?
Adaptor Proteins, Signal Transducing
1
2016
64
0.130
Why?
Cattle
2
2013
127
0.130
Why?
Muscle, Skeletal
1
2019
375
0.130
Why?
Metformin
1
2016
17
0.130
Why?
Hypoglycemic Agents
1
2016
37
0.130
Why?
Computational Biology
2
2014
21
0.130
Why?
Aggrecans
2
2013
56
0.120
Why?
Cognition
1
2024
1339
0.120
Why?
Mice, Transgenic
4
2019
217
0.120
Why?
Protein-Arginine N-Methyltransferases
1
2015
2
0.120
Why?
Risk Factors
3
2024
2295
0.120
Why?
Repressor Proteins
1
2015
38
0.120
Why?
Oligonucleotide Array Sequence Analysis
2
2011
57
0.120
Why?
Collagen Type X
1
2014
3
0.120
Why?
Kidney Failure, Chronic
1
2016
124
0.120
Why?
Leukemia, Myeloid, Acute
1
2015
51
0.120
Why?
Minnesota
1
2014
6
0.120
Why?
Mice
5
2020
1390
0.120
Why?
Hematologic Neoplasms
1
2014
17
0.110
Why?
Microspheres
1
2014
26
0.110
Why?
Cell Differentiation
1
2014
137
0.110
Why?
Metabolic Syndrome
1
2014
58
0.110
Why?
Choroid
1
2013
1
0.110
Why?
Retinal Pigment Epithelium
1
2013
1
0.110
Why?
Iris
1
2013
2
0.110
Why?
Biological Assay
1
2013
8
0.110
Why?
Reference Values
1
2014
185
0.110
Why?
Illinois
1
2014
250
0.110
Why?
src-Family Kinases
1
2013
7
0.110
Why?
Collagen Type IV
2
2004
4
0.110
Why?
In Vitro Techniques
1
2013
173
0.110
Why?
Feasibility Studies
1
2014
219
0.110
Why?
Gene Expression Regulation
2
2014
270
0.110
Why?
Chondroitin Sulfates
1
2013
7
0.100
Why?
Chemokine CCL3
1
2013
8
0.100
Why?
Granuloma
1
2013
13
0.100
Why?
Cell Proliferation
3
2021
174
0.100
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
14
0.100
Why?
Chemokine CXCL12
1
2013
9
0.100
Why?
Interleukin-10
1
2013
18
0.100
Why?
Amino Acid Sequence
5
2015
156
0.100
Why?
Postoperative Complications
1
2019
911
0.100
Why?
Interleukin-1beta
1
2013
50
0.100
Why?
Molecular Sequence Data
5
2015
195
0.100
Why?
Respiratory Tract Infections
1
2013
25
0.100
Why?
Interleukin-6
1
2013
74
0.100
Why?
Decision Support Techniques
1
2012
46
0.100
Why?
Chronic Disease
1
2014
413
0.100
Why?
Pneumonia
1
2013
67
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
74
0.100
Why?
Tumor Necrosis Factor-alpha
1
2013
189
0.100
Why?
Obesity
1
2014
310
0.090
Why?
Animal Experimentation
1
2010
3
0.090
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.090
Why?
Radiography
1
2013
616
0.090
Why?
Serum
1
2010
7
0.090
Why?
Antibodies, Neoplasm
1
2010
12
0.090
Why?
Kaplan-Meier Estimate
3
2017
175
0.080
Why?
Intervertebral Disc
1
2010
121
0.080
Why?
Mass Spectrometry
3
2014
35
0.080
Why?
Case-Control Studies
1
2010
587
0.080
Why?
Sodium Dodecyl Sulfate
1
2008
3
0.080
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
27
0.080
Why?
Phosphoproteins
1
2008
26
0.080
Why?
Preoperative Care
1
2009
117
0.070
Why?
Alzheimer Disease
2
2018
2109
0.070
Why?
Xenograft Model Antitumor Assays
2
2020
24
0.070
Why?
Metals
1
2008
140
0.070
Why?
Cartilage, Articular
1
2011
393
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
137
0.070
Why?
Signal Transduction
3
2014
443
0.070
Why?
Melanoma
2
2004
60
0.060
Why?
Hyaluronan Receptors
1
2004
5
0.060
Why?
Metalloproteases
1
2004
6
0.060
Why?
Peptide Fragments
2
2004
76
0.060
Why?
Brain-Derived Neurotrophic Factor
1
2024
46
0.050
Why?
Real-Time Polymerase Chain Reaction
2
2015
37
0.050
Why?
Adolescent
1
2009
2156
0.050
Why?
Glycosylation
1
2022
19
0.050
Why?
Antibody Formation
1
2022
17
0.050
Why?
Proline
1
2002
8
0.050
Why?
Microsatellite Instability
1
2022
11
0.050
Why?
Tumor Microenvironment
1
2022
20
0.050
Why?
Disease Models, Animal
2
2018
597
0.050
Why?
Drug Screening Assays, Antitumor
1
2021
11
0.050
Why?
Fluorescence
1
2021
9
0.050
Why?
Loss of Heterozygosity
1
2021
6
0.050
Why?
Genomics
1
2021
64
0.050
Why?
Biological Availability
1
2020
17
0.040
Why?
Vasoconstriction
1
2020
15
0.040
Why?
Cross-Sectional Studies
1
2024
890
0.040
Why?
Base Sequence
2
2014
109
0.040
Why?
Tumor Cells, Cultured
2
2015
129
0.040
Why?
Neuropsychological Tests
1
2024
1196
0.040
Why?
RNA, Messenger
2
2015
310
0.040
Why?
beta-Arrestins
1
2019
1
0.040
Why?
Neoplasms, Experimental
1
2019
9
0.040
Why?
Models, Biological
1
2021
321
0.040
Why?
MAP Kinase Signaling System
1
2019
36
0.040
Why?
Antineoplastic Agents
1
2020
197
0.040
Why?
Endoplasmic Reticulum
1
2018
25
0.040
Why?
Action Potentials
1
2018
86
0.040
Why?
Sex Factors
1
2019
461
0.040
Why?
Leukocyte Count
1
2017
61
0.030
Why?
Time-Lapse Imaging
1
2016
5
0.030
Why?
Neoplasm Transplantation
1
2016
12
0.030
Why?
Lymphocytes
1
2017
57
0.030
Why?
A549 Cells
1
2016
11
0.030
Why?
Ubiquitination
1
2016
15
0.030
Why?
Fibrosis
1
2016
30
0.030
Why?
Neoplasm Metastasis
1
2016
107
0.030
Why?
Neutrophils
1
2017
104
0.030
Why?
Atrophy
1
2016
91
0.030
Why?
Graft Survival
1
2016
96
0.030
Why?
Biopsy
1
2016
201
0.030
Why?
Twist-Related Protein 1
1
2015
3
0.030
Why?
Fluorescent Antibody Technique, Indirect
1
2015
7
0.030
Why?
Arginine
1
2015
17
0.030
Why?
Sequence Homology, Amino Acid
1
2015
36
0.030
Why?
Cadherins
1
2015
34
0.030
Why?
RNA, Small Interfering
1
2015
81
0.030
Why?
Blotting, Western
1
2015
147
0.030
Why?
Two-Hybrid System Techniques
1
2014
6
0.030
Why?
Diabetes Mellitus
1
2016
127
0.030
Why?
Enhancer Elements, Genetic
1
2014
8
0.030
Why?
Cyclooxygenase 2
1
2014
28
0.030
Why?
Hypertrophy
1
2014
23
0.030
Why?
Binding Sites
1
2014
73
0.030
Why?
Lipid Metabolism
1
2014
38
0.030
Why?
Nuclear Proteins
1
2015
89
0.030
Why?
Genetic Association Studies
1
2014
83
0.030
Why?
Cognitive Dysfunction
1
2024
1061
0.030
Why?
Insulin Resistance
1
2014
50
0.030
Why?
Wound Healing
1
2015
148
0.030
Why?
Transcription Factors
1
2014
169
0.030
Why?
Proto-Oncogene Proteins c-met
1
2013
3
0.030
Why?
Protein Kinase C beta
1
2013
8
0.030
Why?
Protein Structure, Secondary
2
2004
19
0.030
Why?
Cell Adhesion
2
2004
31
0.030
Why?
DNA Methylation
1
2015
161
0.030
Why?
Ligands
2
2004
39
0.030
Why?
Protein Kinase C
1
2013
48
0.030
Why?
Cell Survival
1
2013
120
0.030
Why?
Enzyme Activation
1
2013
118
0.030
Why?
Phosphorylation
1
2013
148
0.030
Why?
Reference Standards
1
2013
23
0.030
Why?
Oligosaccharides
1
2013
18
0.030
Why?
Cell Membrane
1
2013
91
0.030
Why?
Least-Squares Analysis
1
2011
8
0.020
Why?
Support Vector Machine
1
2011
6
0.020
Why?
Presenilin-1
1
2010
8
0.020
Why?
Smad Proteins
1
2010
3
0.020
Why?
Metabolism
1
2010
6
0.020
Why?
Gels
1
2010
14
0.020
Why?
Chromatography, Liquid
1
2010
23
0.020
Why?
Nitriles
1
2010
14
0.020
Why?
Drug Synergism
1
2010
40
0.020
Why?
Amyloid beta-Protein Precursor
1
2010
17
0.020
Why?
Triazoles
1
2010
29
0.020
Why?
Bone Matrix
1
2010
24
0.020
Why?
Models, Animal
1
2010
114
0.020
Why?
Administration, Oral
1
2010
108
0.020
Why?
Antipsychotic Agents
1
2010
55
0.020
Why?
Proteoglycans
1
2010
138
0.020
Why?
Carrier Proteins
1
2010
102
0.020
Why?
tau Proteins
1
2010
232
0.020
Why?
Cells, Cultured
1
2010
518
0.020
Why?
Aging
1
2018
1541
0.020
Why?
Caseins
1
2008
1
0.020
Why?
Manganese
1
2008
1
0.020
Why?
Phosphopeptides
1
2008
1
0.020
Why?
Ovalbumin
1
2008
6
0.020
Why?
Aluminum
1
2008
9
0.020
Why?
Iron
1
2008
14
0.020
Why?
Serum Albumin
1
2008
25
0.020
Why?
Titanium
1
2008
172
0.020
Why?
DNA Primers
1
2004
52
0.010
Why?
Antigens, CD
1
2004
50
0.010
Why?
Stereoisomerism
1
2002
3
0.010
Why?
Drug Stability
1
2002
3
0.010
Why?
Biophysical Phenomena
1
2002
29
0.010
Why?
Basement Membrane
1
2002
11
0.010
Why?
Biophysics
1
2002
35
0.010
Why?
Borgia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (322)
Explore
_
Co-Authors (61)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_